O tratamento Têm a possibilidade de ser feito utilizando aplicador em linha e/ou caneta depende da condição da pele e do formato do rosto do paciente.
Injection in the back of the hand may result in temporary difficulty performing activities. RADIESSE® may cause nodules, bumps or lumps in the back of the hand and can last up to 1 year.
Calcium hydroxylapatite, or CaHA, is what makes Radiesse unique as an injectable aesthetic treatment. It’s the first and only CaHA portfolio available that provides both immediate, conterraneo-looking results and long-term improvement—a year or more in many patients.1-8
Use of RADIESSE® in the dorsum of the hand may result in significant swelling of the dorsum of the hand.
Check out these common questions for more info about Radiesse Injectables and what your patients can expect from treatment.
Calcium hydroxylapatite, or CaHA, is what makes Radiesse unique as a dermal filler treatment. Radiesse is composed of CaHA suspended in an aqueous gel copyright.3
To get more personalized information, the best thing to do is to schedule a consultation with a healthcare provider.
Use of these products in any person with active skin inflammation bioestimulador de colágeno or infection in or near the treatment should be deferred until the inflammatory or infectious process is controlled.
In order to minimize the risk of potential complications, this product should only be used by healthcare practitioners who have appropriate training, experience and who are knowledgeable about the anatomy at and around the injection site.
Radiesse (+) injectable implant is also indicated for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to severe loss of jawline contour in adults over the age of 21.
Patients should minimize strenuous activity and exposure of the treated area to extensive sun or heat exposure for approximately 24 hours after treatment or until any initial swelling and redness has resolved.
Radiesse (+) injectable implant is also indicated for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to severe loss of jawline contour in adults over the age of 21.
1 Successful completion of this indication-specific training by providers is necessary prior to their administration of fillers for such new indications.
You should minimize strenuous activity and avoid extensive sun or heat exposure for about 24 hours after treatment and until any swelling or redness has resolved.